🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
DHR
NYSE
🇺🇸 US
Danaher Corporation
Healthcare
31Score
DipBuster Score™
$201.11
$2.72 (-1.33%)
Live price · Source: Yahoo
52-Week Position
$160.93
49% of range
$242.80
Beta
0.823
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.823
52W High$242.80
52W Low$160.93
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (49% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position49% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.823
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Danaher Corporation (DHR), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-05-15 | Lamanna Charles W | BUY | 1,699 |
| 2026-05-15 | Lamanna Charles W | BUY | 680 |
| 2026-05-15 | Couchara Georgeann | SELL | 281 |
| 2026-05-15 | Sanders A Shane | BUY | 1,699 |
| 2026-05-15 | Sanders A Shane | BUY | 680 |
| 2026-05-15 | Stevens Raymond C | BUY | 1,699 |
| 2026-05-15 | Stevens Raymond C | BUY | 680 |
| 2026-05-15 | List Teri | BUY | 1,699 |
| 2026-05-15 | List Teri | BUY | 680 |
| 2026-05-15 | Dewan Feroz | BUY | 1,699 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.823
Dividend/yrNone
52W High$242.80
52W Low$160.93
52-Week Range
$160.93Now$242.80
49% through annual range
From 52W High−17.2%
From 52W Low+25%
📖 Plain English Summary
Danaher Corporation is at 49% of its 52-week range. Beta 0.823 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for DHR
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — DHR
Heuristic · balance sheet, insider filings, price data, academic research
Danaher Corporation — DipBuster Score 31/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Danaher Corporation free
Add DHR to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
20/25
Momentum & Volume
6/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
61
/100 · STRONG
dip depth
24/25
oversold rsi
12/25
mean reversion
15/15
insider zone
0/25
capitulation
10/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 31/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and se…
Sector
Healthcare
Market
🇺🇸 US
CEO
Rainer Blair
Staff
61,000 employees
Website